COSM
Cosmos Health Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.27
+2.59%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 73.7M | 65.3M | 54.4M | 53.4M | 50.3M |
| Cost of Revenue | 66.2M | 57.4M | 50.1M | 49.0M | 44.4M |
| Gross Profit | 7.6M | 7.9M | 4.3M | 4.3M | 6.0M |
| Operating Expenses | |||||
| R&D Expense | 497.6K | 519.4K | 533.3K | — | — |
| SG&A Expense | 20.5M | 22.5M | 12.1M | 25.6M | 13.2M |
| General & Admin Expense | 20.3M | 22.4M | 11.7M | 24.4M | 12.6M |
| Selling & Marketing Expense | 218.0K | 150.2K | 355.0K | 1.2M | 630.1K |
| Other Expenses | 4.7M | 1.4M | 7.2M | 614.4K | 188.9K |
| Total Operating Expenses | 25.7M | 24.4M | 19.9M | 26.2M | 13.4M |
| Cost and Expenses | 91.9M | 81.8M | 70.0M | 75.2M | 57.8M |
| Operating Income (EBIT) | (18.2M) | (16.5M) | (15.5M) | (21.8M) | (7.5M) |
| Non-Operating | |||||
| Interest Income | 291.7K | 396.4K | 406.4K | 662.9K | 236.3K |
| Interest Expense | 3.5M | 2.6M | 1.0M | 866.5K | 4.0M |
| Net Interest Income | (3.2M) | (2.2M) | (605.9K) | (203.6K) | (3.7M) |
| Other Non-Op Income/Expense | (6.2M) | (2.6M) | (638.2K) | 3.3M | (5.6M) |
| Non-Operating Income (excl Interest) | 2.7M | (18.5K) | (374.1K) | (4.2M) | 1.6M |
| EBT (Pre-Tax Income) | (24.4M) | (19.1M) | (16.2M) | (18.5M) | (13.1M) |
| Income Tax Expense | — | — | — | — | 775.1K |
| Bottom Line | |||||
| Net Income | (24.4M) | (19.1M) | (16.2M) | (18.5M) | (13.8M) |
| Earnings from Cont. Ops | (24.4M) | (19.1M) | (16.2M) | (18.5M) | (13.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (24.4M) | (19.1M) | (22.4M) | (25.8M) | (63.9M) |
| Per Share | |||||
| Basic EPS | ($0.66) | ($0.63) | ($1.17) | ($2.15) | ($33.16) |
| Diluted EPS | ($0.66) | ($0.63) | ($1.17) | ($2.15) | ($33.16) |
| Revenue Per Share | $1.23 | $2.15 | $2.84 | $4.46 | $26.11 |
| Shares | |||||
| Basic Shares Outstanding | 59.9M | 30.3M | 19.1M | 12.0M | 1.9M |
| Diluted Shares Outstanding | 59.9M | 30.3M | 19.1M | 12.0M | 1.9M |
| Profitability Metrics | |||||
| EBITDA | (19.5M) | (15.2M) | (13.9M) | (17.1M) | (8.9M) |
| D&A | 1.4M | 1.4M | 1.2M | 614.4K | 188.9K |
| EBIT | (20.9M) | (16.5M) | (15.2M) | (17.7M) | (9.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026